Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are ...

Scientists are investigating whether a concentrated hop extract can trigger the gut’s “bitter brake,” a natural signaling pathway that may help reduce hunger and support appetite control.

Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...

The child was diagnosed with Hyper IgE Syndrome and, during treatment, was later found to have Burkitt lymphoma, resulting in ...

Amylyx (AMLX) downgraded to Buy after AMX0035 PSP halt; focus shifts to avexitide Phase 3 with Q3 2026 data and strong cash ...

While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting ...

The "Citrus Mechanism" popularized by CitrusBurn in 2026 represents a departure from 20th-century weight loss philosophy.

A growing body of preclinical research is converging on a provocative idea: that the mental health benefits of physical ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Carvedilol is a non-selective beta-blocker that helps relax blood vessels and improves blood flow. Metoprolol is a cardioselective beta-blocker, meaning it primarily targets the heart's beta-1 ...